Financials Stevanato Group S.p.A.

Equities

STVN

IT0005452658

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
27.54 USD +0.07% Intraday chart for Stevanato Group S.p.A. +3.03% +0.92%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,227 4,445 6,583 7,061 - -
Enterprise Value (EV) 2 5,037 4,445 6,583 7,412 7,292 7,139
P/E ratio 39 x 31.4 x 45.5 x 42.4 x 35.5 x 29.1 x
Yield 0.25% - - 0.25% 0.28% 0.29%
Capitalization / Revenue 6.19 x 4.52 x 6.06 x 5.91 x 5.26 x 4.69 x
EV / Revenue 5.97 x 4.52 x 6.06 x 6.2 x 5.43 x 4.75 x
EV / EBITDA 23.1 x 16.9 x 22.6 x 23.1 x 19.5 x 16.5 x
EV / FCF 197 x -33.7 x - -132 x 124 x 50.8 x
FCF Yield 0.51% -2.96% - -0.76% 0.8% 1.97%
Price to Book 6.16 x - - 5.26 x 4.65 x 4.12 x
Nbr of stocks (in thousands) 264,699 264,699 266,234 273,722 - -
Reference price 3 22.45 17.97 27.29 27.54 27.54 27.54
Announcement Date 3/8/22 3/2/23 3/7/24 - - -
1USD in Million2EUR in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 843.9 983.7 1,085 1,195 1,342 1,504
EBITDA 1 - 218.3 263.6 291.5 321.2 373.7 433.8
EBIT 1 - 161.9 198.7 213 230 266.8 319.6
Operating Margin - 19.18% 20.2% 19.62% 19.25% 19.88% 21.24%
Earnings before Tax (EBT) 1 - 165.7 187.6 189.6 210.1 255.7 310.2
Net income 1 78.51 134.3 143 145.7 161 194.7 235.1
Net margin - 15.91% 14.54% 13.42% 13.47% 14.5% 15.63%
EPS 2 1.071 0.5756 0.5726 0.5996 0.6494 0.7749 0.9473
Free Cash Flow 1 - 25.6 -131.7 - -56.19 58.62 140.5
FCF margin - 3.03% -13.39% - -4.7% 4.37% 9.34%
FCF Conversion (EBITDA) - 11.73% - - - 15.69% 32.38%
FCF Conversion (Net income) - 19.06% - - - 30.11% 59.75%
Dividend per Share 2 - 0.0555 - - 0.0690 0.0765 0.0800
Announcement Date 4/30/21 3/8/22 3/2/23 3/7/24 - - -
1EUR in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 214.5 232.6 212.1 234.2 245.3 292.1 238 255.3 271.4 320.6 237.5 276.5 308.2 361.8 270
EBITDA 1 51.4 58.9 54 61.8 65.8 81.9 61.9 68.2 74.7 86.7 62.24 72.75 85.21 99.18 71.9
EBIT 1 36.5 43.8 38.8 45.9 49.1 64.8 43.6 48.7 54.2 66.6 40.81 49.83 61.18 74.89 50.48
Operating Margin 17.02% 18.83% 18.29% 19.6% 20.02% 22.18% 18.32% 19.08% 19.97% 20.77% 17.18% 18.02% 19.85% 20.7% 18.7%
Earnings before Tax (EBT) 1 22.4 53.7 36.3 41.5 46 63.8 36 44.3 50.4 58.8 32.75 45.05 56.5 70.95 43.4
Net income 1 18.6 44.6 27.8 30.6 36.3 48.3 28.3 34.3 37.9 45.2 28 35.14 43.2 54.09 36.23
Net margin 8.67% 19.17% 13.11% 13.07% 14.8% 16.54% 11.89% 13.44% 13.96% 14.1% 11.79% 12.71% 14.02% 14.95% 13.42%
EPS 2 0.0811 0.1846 0.1053 0.1228 0.1400 0.1909 0.1210 0.1429 0.1485 0.1853 0.1138 0.1426 0.1746 0.2180 0.1445
Dividend per Share 2 - 0.0555 - - - - - - - - - - - - -
Announcement Date 11/9/21 3/8/22 5/10/22 8/4/22 11/8/22 3/2/23 5/4/23 7/28/23 10/31/23 3/7/24 - - - - -
1EUR in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - 351 231 78.1
Net Cash position 1 - 190 - - - - -
Leverage (Debt/EBITDA) - - - - 1.094 x 0.6173 x 0.1801 x
Free Cash Flow 1 - 25.6 -132 - -56.2 58.6 140
ROE (net income / shareholders' equity) - 23.3% - - 13.2% 13.7% 14.2%
ROA (Net income/ Total Assets) - 11.3% - - 7.3% 7.9% 8.8%
Assets 1 - 1,193 - - 2,205 2,464 2,671
Book Value Per Share 2 - 3.640 - - 5.240 5.930 6.690
Cash Flow per Share 2 - 0.5700 0.4100 - 1.250 1.240 1.500
Capex 1 - 108 235 - 322 237 231
Capex / Sales - 12.76% 23.89% - 26.98% 17.62% 15.38%
Announcement Date 4/30/21 3/8/22 3/2/23 3/7/24 - - -
1EUR in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
27.54 USD
Average target price
35 USD
Spread / Average Target
+27.08%
Consensus
  1. Stock Market
  2. Equities
  3. STVN Stock
  4. Financials Stevanato Group S.p.A.